ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000125970 | RALY | RALY heterogeneous nuclear ribonucleoprotein | [
"Q9UKM9"
] | 20 | 33993646-34108308 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040971",
"HPA043614"
] | [
"HNRPCL2",
"P542"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing",
"Transcription",
"Transcription regulation"
] | [
"Ribonucleoprotein",
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Vesicles"
] | [] | [] | Enhanced | Enhanced | null | 81 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 30: White matter - Myelination | Cluster 62: Non-specific - Plasma proteins | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,692 | 2 |
ENSG00000125971 | DYNLRB1 | Dynein light chain roadblock-type 1 | [
"Q9NP97"
] | 20 | 34516395-34540958 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB009845"
] | [
"DNCL2A",
"DNLC2A",
"ROBLD1"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transport"
] | [
"Motor protein"
] | [] | [] | [] | [] | [] | null | Approved | null | 42 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 62: Non-specific - Plasma proteins | Cluster 15: Non-specific - Protein processing | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,693 | 5 |
ENSG00000125975 | C20orf173 | Chromosome 20 open reading frame 173 | [
"Q96LM9"
] | 20 | 35523186-35529652 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA076859"
] | [
"dJ477O4.4"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 37: Neurons - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 23: Testis - Spermatogenesis | Tissue enriched | Detected in single | 170 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 8 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,694 | 3 |
ENSG00000125977 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit beta | [
"P20042"
] | 20 | 34088309-34112243 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB034415",
"HPA041262",
"HPA041332",
"HPA065768"
] | [
"EIF2",
"EIF2beta",
"PPP1R67"
] | [
"Cancer-related genes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Protein biosynthesis"
] | [
"Initiation factor"
] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum"
] | [
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 71 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 62: Non-specific - Plasma proteins | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | 5,695 | 2 |
ENSG00000125991 | ERGIC3 | ERGIC and golgi 3 | [
"Q9Y282"
] | 20 | 35542038-35557634 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA015242",
"HPA015968"
] | [
"C20orf47",
"CGI-54",
"Erv46",
"NY-BR-84",
"PRO0989",
"SDBCAG84"
] | [
"Predicted membrane proteins"
] | [
"ER-Golgi transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 205 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 36: Choroid plexus - Mixed function | Cluster 62: Non-specific - Plasma proteins | Cluster 15: Non-specific - Protein processing | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,696 | 7 |
ENSG00000125995 | ROMO1 | Reactive oxygen species modulator 1 | [
"P60602"
] | 20 | 35699272-35700984 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA012782"
] | [
"bA353C18.2",
"C20orf52",
"MTGMP"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Transporters"
] | [] | [
"Antibiotic",
"Antimicrobial"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 62: Non-specific - Plasma proteins | Cluster 97: Non-specific - Cellular respiration | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,697 | 9 |
ENSG00000125999 | BPIFB1 | BPI fold containing family B member 1 | [
"Q8TDL5"
] | 20 | 33273480-33309871 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024256"
] | [
"bA49G10.6",
"C20orf114",
"dJ1187J4.1",
"LPLUNC1",
"MGC14597",
"VEMSGP"
] | [
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Immunity",
"Innate immunity"
] | [] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Immunity"
] | null | Enhanced | null | 9 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 60: Stomach - Digestion | Group enriched | Detected in some | 4 | Cancer enriched | Detected in many | 7 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 8 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,699 | 3 |
ENSG00000126001 | CEP250 | Centrosomal protein 250 | [
"Q9BV73"
] | 20 | 35455164-35519280 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA064875",
"HPA069380"
] | [
"C-NAP1",
"CEP2"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cilium biogenesis/degradation"
] | [] | [
"Cone-rod dystrophy",
"Deafness",
"Disease variant"
] | [
"Centrosome"
] | [
"Basal body"
] | [] | [] | Enhanced | null | null | 18 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 72: Neuronal - Signal transduction | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 4 | [
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | 5,700 | 8 |
ENSG00000126003 | PLAGL2 | PLAG1 like zinc finger 2 | [
"Q9UPG8"
] | 20 | 32192504-32207743 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005900",
"HPA077084"
] | [
"ZNF900"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 36 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 16: Non-specific - Transcription | Cluster 62: Non-specific - Plasma proteins | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Group enriched | Detected in many | 7 | 2 | 0 | 2 | [
"Lung Squamous Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 5,701 | 9 |
ENSG00000126005 | MMP24OS | MMP24 opposite strand | [
"A0A0U1RRL7"
] | 20 | 35201745-35278131 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"MMP24-AS1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 42: Choroid plexus - Mitochondria | Cluster 62: Non-specific - Plasma proteins | Cluster 7: Non-specific - Transcription | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 5,702 | 5 |
ENSG00000126010 | GRPR | Gastrin releasing peptide receptor | [
"P30550"
] | X | 16123565-16153518 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA069604"
] | [
"BB2",
"BB2R",
"BRS2"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [
"Plasma membrane"
] | [] | [] | [] | Supported | null | null | null | null | null | null | Cluster 14: Neurons - Synaptic function | Cluster 3: Rhabdoid - Membrane components | Cluster 109: Neurons - Neuronal signaling | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in some | 10 | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in some | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,703 | 3 |
ENSG00000126016 | AMOT | Angiomotin | [
"Q4VCS5"
] | X | 112774503-112840831 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067290",
"HPA067853"
] | [
"KIAA1071"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cell Junctions"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Enhanced | null | 81 | null | null | null | Cluster 39: Astrocytes - Mixed function | Cluster 70: DU4475 - Unknown function | Cluster 30: Epididymal principal cells - Sperm storage microenvironment | Cluster 22: Epididymis - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 5,705 | 5 |
ENSG00000126062 | TMEM115 | Transmembrane protein 115 | [
"Q12893"
] | 3 | 50354750-50359521 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB006319",
"HPA015497"
] | [
"PL6"
] | [
"Plasma proteins",
"Predicted membrane proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Supported | null | 13 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 44: Non-specific - Mixed function | Cluster 8: Non-specific - Basic cellular processes | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,706 | 3 |
ENSG00000126067 | PSMB2 | Proteasome 20S subunit beta 2 | [
"P49721"
] | 1 | 35599541-35641526 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026322",
"HPA026324"
] | [
"HC7-I"
] | [
"Enzymes",
"Essential proteins",
"FDA approved drug targets",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [] | [
"FDA approved drug targets"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Approved | null | 154 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 30: White matter - Myelination | Cluster 37: Non-specific - mRNA processing | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Colon Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 5,707 | 9 |
ENSG00000126070 | AGO3 | Argonaute RISC catalytic component 3 | [
"Q9H9G7"
] | 1 | 35930718-36072500 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048342",
"HPA067849",
"HPA075436"
] | [
"EIF2C3",
"FLJ12765",
"hAGO3"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"RNA-mediated gene silencing",
"Translation regulation"
] | [
"Endonuclease",
"Hydrolase",
"Nuclease",
"Ribonucleoprotein",
"RNA-binding"
] | [] | [
"Cytoplasmic bodies"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 33 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 11: White matter - Signal transduction | Cluster 37: Non-specific - mRNA processing | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 5,708 | 4 |
ENSG00000126088 | UROD | Uroporphyrinogen decarboxylase | [
"P06132"
] | 1 | 45010950-45015575 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027468",
"HPA028668",
"HPA030350"
] | [] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Heme biosynthesis",
"Porphyrin biosynthesis"
] | [
"Decarboxylase",
"Lyase"
] | [
"Disease variant"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Supported | Uncertain | null | 7 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,709 | 8 |
ENSG00000126091 | ST3GAL3 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | [
"Q11203"
] | 1 | 43705824-43931165 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA051102"
] | [
"MRT12",
"SIAT6"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Uncertain | null | 2 | null | null | Cluster 24: Non-specific - Transcription | Cluster 38: Sub-cortical - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 22: Non-specific - Basic cellular functions | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Lung Squamous Cell Carcinoma"
] | [
"Rectum Adenocarcinoma"
] | [
"Lung Squamous Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 5,710 | 2 |
ENSG00000126106 | TMEM53 | Transmembrane protein 53 | [
"Q6P2H8"
] | 1 | 44635238-44674481 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA021134"
] | [
"FLJ22353",
"NET4"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Developmental protein"
] | [
"Dwarfism"
] | [
"Golgi apparatus"
] | [
"Focal adhesion sites"
] | [] | [] | Approved | Approved | null | 6 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 47: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 8 | Immune cell enriched | Detected in all | 4 | 1 | 0 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Ovary Serous Cystadenocarcinoma"
] | 5,711 | 3 |
ENSG00000126107 | HECTD3 | HECT domain E3 ubiquitin protein ligase 3 | [
"Q5T447"
] | 1 | 45002540-45011324 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA027467"
] | [
"FLJ21156"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [] | [] | [] | [] | null | Approved | null | 40 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 6: Non-specific - Immune response | Cluster 37: Non-specific - mRNA processing | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 5,712 | 7 |
ENSG00000126215 | XRCC3 | X-ray repair cross complementing 3 | [
"O43542"
] | 14 | 103697609-103715504 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062422",
"HPA068953"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA recombination",
"DNA repair"
] | [
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | null | null | 17 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 6: Non-specific - Immune response | Cluster 30: Non-specific - Gene expression regulation | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 58: Skin - Keratinization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,714 | 5 |
ENSG00000126216 | TUBGCP3 | Tubulin gamma complex associated protein 3 | [
"Q96CW5"
] | 13 | 112485011-112588205 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA043913"
] | [
"GCP3",
"SPBC98",
"Spc98p"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Approved | null | 17 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 30: White matter - Myelination | Cluster 19: Non-specific - Unknown function | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,715 | 6 |
ENSG00000126217 | MCF2L | MCF.2 cell line derived transforming sequence like | [
"O15068"
] | 13 | 112894378-113099742 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ARHGEF14",
"DBS",
"KIAA0362",
"OST"
] | [
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor"
] | [
"Proto-oncogene"
] | [] | [] | [] | [] | null | null | null | 3 | null | null | null | Cluster 37: Neurons - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 71: Cerebellum - Nervous system development | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 5,716 | 5 |
ENSG00000126218 | F10 | Coagulation factor X | [
"P00742"
] | 13 | 113122799-113149529 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Candidate cardiovascular disease genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Blood coagulation",
"Hemostasis"
] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Blood coagulation"
] | null | null | null | 11 | null | null | null | Cluster 49: Hindbrain - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 108: Fibroblasts - ECM organization | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 9 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Pancreatic Adenocarcinoma"
] | [
"Lung Squamous Cell Carcinoma"
] | [
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 5,717 | 6 |
ENSG00000126226 | PCID2 | PCI domain containing 2 | [
"Q5JVF3"
] | 13 | 113177536-113208715 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA069107",
"HPA073074"
] | [
"FLJ11305"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"mRNA transport",
"Protein transport",
"Translocation",
"Transport"
] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | Approved | null | 14 | null | Yes | Cluster 5: Non-specific - Cell proliferation | Cluster 31: Non-specific - Transcription | Cluster 19: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,718 | 1 |
ENSG00000126231 | PROZ | Protein Z, vitamin K dependent plasma glycoprotein | [
"P22891"
] | 13 | 113158648-113172386 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA052006"
] | [
"PZ"
] | [
"Candidate cardiovascular disease genes",
"Enzymes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Blood coagulation",
"Hemostasis"
] | [
"Serine protease homolog"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Blood coagulation"
] | null | Supported | null | 1 | null | null | null | Cluster 5: Non-specific - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 25: Hepatocytes - Plasma protein synthesis & secretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enriched | Detected in some | 8 | Low cancer specificity | Detected in some | null | Cancer enriched | Detected in some | 11 | Cell type enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,719 | 4 |
ENSG00000126243 | LRFN3 | Leucine rich repeat and fibronectin type III domain containing 3 | [
"Q9BTN0"
] | 19 | 35935358-35946624 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA048923"
] | [
"FIGLER1",
"MGC2656",
"SALM4"
] | [
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 19 | null | null | Cluster 1: T-cells - Unknown function | Cluster 32: Cerebral cortex - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,721 | 7 |
ENSG00000126246 | IGFLR1 | IGF like family receptor 1 | [
"Q9H665"
] | 19 | 35738801-35742453 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA012369",
"HPA070778"
] | [
"FLJ22573",
"TMEM149",
"U2AF1L4"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [
"Nucleoplasm",
"Plasma membrane"
] | [] | [
"Intracellular and membrane"
] | [
"Receptor"
] | Approved | Uncertain | null | 1 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 44: Non-specific - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in all | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 5,722 | 4 |
ENSG00000126247 | CAPNS1 | Calpain small subunit 1 | [
"P04632"
] | 19 | 36139953-36150353 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006872"
] | [
"30K",
"CANP",
"CANPS",
"CAPN4",
"CDPS"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 16 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 1: Neurons - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 81: Squamous epithelium - Keratinization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 5,723 | 5 |
ENSG00000126251 | GPR42 | G protein-coupled receptor 42 | [
"O15529"
] | 19 | 35371068-35372962 | Evidence at protein level | No human protein/transcript evidence | Evidence at protein level | Evidence at protein level | [
"HPA044681"
] | [
"FFAR3L",
"GPR41L",
"GPR42P"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 88 | null | null | null | null | null | Cluster 58: Mast cells - Allergic inflammatory responses | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,725 | 2 |
ENSG00000126254 | RBM42 | RNA binding motif protein 42 | [
"Q9BTD8"
] | 19 | 35629030-35637686 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043671"
] | [
"MGC10433"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Supported | null | 232 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 27: Non-specific - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,726 | 5 |
ENSG00000126259 | KIRREL2 | Kirre like nephrin family adhesion molecule 2 | [
"Q6UWL6"
] | 19 | 35855861-35867136 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071587",
"HPA074326"
] | [
"DKFZp564A1164",
"FILTRIN",
"MGC15718",
"NEPH3",
"NLG1"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Centriolar satellite"
] | [] | [
"Intracellular and membrane"
] | [
"No annotated function"
] | Supported | Enhanced | null | 2 | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in some | 6 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,727 | 7 |
ENSG00000126261 | UBA2 | Ubiquitin like modifier activating enzyme 2 | [
"Q9UBT2"
] | 19 | 34428352-34471251 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041436"
] | [
"FLJ13058",
"HRIHFB2115",
"SAE2"
] | [
"Disease related genes",
"Essential proteins",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [
"Disease variant",
"Ectodermal dysplasia"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 23 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 55: Non-specific - Transcription | Cluster 4: Non-specific - Transcription | Cluster 110: Mural cells - ECM organization | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,728 | 1 |
ENSG00000126262 | FFAR2 | Free fatty acid receptor 2 | [
"O15552"
] | 19 | 35443907-35451767 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA023985"
] | [
"FFA2R",
"GPR43"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Immunity",
"Inflammatory response"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Approved | null | 93 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 10: Ciliated cells - Ion channel activity | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 7 | Group enriched | Detected in many | 25 | 0 | 0 | 0 | [] | [] | [] | 5,729 | 5 |
ENSG00000126264 | HCST | Hematopoietic cell signal transducer | [
"Q9UBK5"
] | 19 | 35902529-35904377 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB034435",
"HPA063026"
] | [
"DAP10",
"DKFZP586C1522",
"KAP10",
"PIK3AP"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Golgi apparatus",
"Vesicles",
"Plasma membrane"
] | [] | [] | [] | Uncertain | Enhanced | null | 2 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Group enriched | Detected in many | 13 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,730 | 5 |
ENSG00000126266 | FFAR1 | Free fatty acid receptor 1 | [
"O14842"
] | 19 | 35347902-35353864 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048933"
] | [
"FFA1R",
"GPR40"
] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [
"Plasma membrane"
] | [] | [] | [] | Supported | null | null | null | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 46: Lymphoma - Humoral immune response | Cluster 76: Pancreatic endocrine cells - Endocrine signaling | Cluster 68: Non-specific - Basic cellular processes | Group enriched | Detected in some | 6 | Cancer enhanced | Detected in single | null | Cancer enriched | Detected in single | 9 | Cell type enriched | Detected in some | 4 | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 5,731 | 9 |
ENSG00000126267 | COX6B1 | Cytochrome c oxidase subunit 6B1 | [
"P14854"
] | 19 | 35648323-35658782 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004192"
] | [
"COX6B",
"COXG"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [
"Principal piece"
] | [] | [] | Supported | Supported | null | 8 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 14: Neurons - Synaptic function | Cluster 4: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 5,732 | 1 |
ENSG00000126351 | THRA | Thyroid hormone receptor alpha | [
"P10827"
] | 17 | 40058290-40093867 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA009654",
"CAB023349"
] | [
"AR7",
"EAR-7.1/EAR-7.2",
"ERBA",
"ERBA1",
"NR1A1",
"THRA1",
"THRA2",
"THRA3",
"TRalpha"
] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Nuclear receptors",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Receptor"
] | [
"Cancer-related genes",
"Congenital hypothyroidism",
"Disease variant",
"FDA approved drug targets"
] | [
"Cytosol"
] | [] | [] | [] | Uncertain | Approved | null | 34 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 33: Neurons - Mixed function | Cluster 65: Non-specific - Unknown function | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in all | 5 | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,734 | 4 |
ENSG00000126353 | CCR7 | C-C motif chemokine receptor 7 | [
"P32248"
] | 17 | 40553769-40565472 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003796",
"HPA031383",
"HPA074467"
] | [
"BLR2",
"CD197",
"CDw197",
"CMKBR7",
"EBI1"
] | [
"Cancer-related genes",
"CD markers",
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Cancer-related genes"
] | [
"Mitochondria"
] | [] | [] | [] | Enhanced | Enhanced | null | null | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 11: White matter - Signal transduction | Cluster 21: Lymphoma - Adaptive immune response | Cluster 82: Dendritic cells - Antigen presentation | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 7 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in all | null | 4 | 2 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 5,735 | 9 |
ENSG00000126391 | FRMD8 | FERM domain containing 8 | [
"Q9BZ67"
] | 11 | 65386621-65413525 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002861"
] | [
"FKSG44",
"FLJ90369",
"iTAP"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Centriolar satellite"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Approved | Approved | null | 5 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 11: White matter - Signal transduction | Cluster 69: Skin cancer - ECM organization | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 5,737 | 1 |
ENSG00000126432 | PRDX5 | Peroxiredoxin 5 | [
"P30044"
] | 11 | 64318121-64321811 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB008661",
"HPA037915",
"HPA037916"
] | [
"ACR1",
"AOEB166",
"B166",
"MGC117264",
"MGC142283",
"MGC142285",
"PLP",
"PMP20",
"PRDX6",
"PRXV",
"SBBI10"
] | [
"Enzymes",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Antioxidant",
"Oxidoreductase",
"Peroxidase"
] | [
"FDA approved drug targets"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Enhanced | null | 17 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 44: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 5,738 | 5 |
ENSG00000126456 | IRF3 | Interferon regulatory factor 3 | [
"Q14653"
] | 19 | 49659569-49665875 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004895",
"CAB013018"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Antiviral defense",
"Host-virus interaction",
"Immunity",
"Innate immunity",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Disease variant"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 52 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 27: Non-specific - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 65: Non-specific - Cell growth & division | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,740 | 7 |
ENSG00000126457 | PRMT1 | Protein arginine methyltransferase 1 | [
"Q99873"
] | 19 | 49675786-49689029 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB022550",
"HPA069769",
"HPA072136"
] | [
"ANM1",
"HCP1",
"HRMT1L2"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Methyltransferase",
"Transferase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 197 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 27: Non-specific - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,741 | 6 |
ENSG00000126458 | RRAS | RAS related | [
"P10301"
] | 19 | 49635292-49640143 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB010160",
"HPA060364",
"CAB069439"
] | [
"R-Ras"
] | [
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | 7 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 47: Endothelial cells - Vasculature | Cluster 64: Connective tissue cells - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 4 | 4 | 0 | 4 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 5,742 | 2 |
ENSG00000126460 | PRRG2 | Proline rich and Gla domain 2 | [
"O14669"
] | 19 | 49580646-49591004 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA010702"
] | [
"PRGP2"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 4 | No | null | null | Cluster 25: Non-specific - Transcription | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 33: Thyroid gland - Tissue development | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 5,743 | 7 |
ENSG00000126461 | SCAF1 | SR-related CTD associated factor 1 | [
"Q9H7N4"
] | 19 | 49642209-49658642 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA046828",
"HPA054593"
] | [
"FLJ00034",
"SR-A1"
] | [
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 15 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 32: Cerebral cortex - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,744 | 9 |
ENSG00000126464 | PRR12 | Proline rich 12 | [
"Q9ULL5"
] | 19 | 49591182-49626439 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA011959"
] | [
"KIAA1205"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Intellectual disability"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 7 | null | null | null | Cluster 32: Cerebral cortex - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 7: Non-specific - Transcription | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,745 | 6 |
ENSG00000126467 | TSKS | Testis specific serine kinase substrate | [
"Q9UJT2"
] | 19 | 49739753-49763306 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045729"
] | [
"PPP1R161",
"TSSKS"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 6 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 35: Non-specific - DNA binding | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 79: Testis - Spermatogenesis | Tissue enriched | Detected in some | 66 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 5,746 | 8 |
ENSG00000126500 | FLRT1 | Fibronectin leucine rich transmembrane protein 1 | [] | 11 | 64035931-64119173 | Evidence at transcript level | Evidence at transcript level | null | null | [
"HPA054589"
] | [
"MGC21624",
"SPG68"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 55: Myocytes - Oxidative muscle function | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 5,747 | 1 |
ENSG00000126522 | ASL | Argininosuccinate lyase | [
"P04424"
] | 7 | 66075800-66094697 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003696",
"HPA016646"
] | [
"ASAL"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Amino-acid biosynthesis",
"Arginine biosynthesis",
"Urea cycle"
] | [
"Lyase"
] | [
"Disease variant"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 3 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 44: Non-specific - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 65: Non-specific - Cell growth & division | Cluster 31: Liver - Metabolism & Coagulation | Tissue enriched | Detected in all | 6 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,748 | 8 |
ENSG00000126524 | SBDS | SBDS ribosome maturation factor | [
"Q9Y3A5"
] | 7 | 66987680-66995693 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028891"
] | [
"CGI-97",
"FLJ10917",
"SDO1",
"SDS",
"SWDS"
] | [
"Cancer-related genes",
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis"
] | [] | [
"Cancer-related genes",
"Disease variant"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 41 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 39: Non-specific - Transcription | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 5,749 | 5 |
ENSG00000126545 | CSN1S1 | Casein alpha s1 | [
"P47710"
] | 4 | 69931068-69946574 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035659",
"HPA057031"
] | [
"CASA",
"CSN1"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Milk protein"
] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted in female reproductive system"
] | [
"Other"
] | null | Enhanced | null | 4 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 72: Neuronal - Signal transduction | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 55: Breast - Lactation | Tissue enriched | Detected in some | 86 | Cancer enriched | Detected in single | 16 | Group enriched | Detected in some | 68 | Cell type enriched | Detected in some | 8,235 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,750 | 8 |
ENSG00000126549 | STATH | Statherin | [
"P02808"
] | 4 | 69995966-70002570 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044569"
] | [
"STR"
] | [
"Plasma proteins",
"Predicted secreted proteins",
"Transporters"
] | [
"Biomineralization"
] | [] | [] | [] | [] | [
"Secreted to digestive system"
] | [
"Other"
] | null | Enhanced | null | 21 | null | null | null | null | Cluster 33: Sarcoma - Muscle contraction | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 82: Salivary gland - Secretion | Tissue enriched | Detected in some | 921 | Cancer enriched | Detected in single | 7 | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 18 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,751 | 8 |
ENSG00000126550 | HTN1 | Histatin 1 | [
"P15515"
] | 4 | 70050438-70058848 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA077315"
] | [
"HIS1"
] | [
"Predicted secreted proteins",
"Transporters"
] | [
"Biomineralization"
] | [
"Antibiotic",
"Antimicrobial",
"Fungicide"
] | [] | [] | [] | [
"Secreted to digestive system"
] | [
"Defense"
] | null | Approved | null | 2 | null | null | null | null | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 82: Salivary gland - Secretion | Tissue enriched | Detected in some | 2,599 | Cancer enriched | Detected in single | 23 | Not detected | Not detected | null | Group enriched | Detected in some | 13 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,752 | 5 |
ENSG00000126561 | STAT5A | Signal transducer and activator of transcription 5A | [
"P42229"
] | 17 | 42287547-42311943 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003860",
"HPA027873",
"HPA042128",
"HPA049883",
"HPA051156"
] | [
"MGF",
"STAT5"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Lactation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Enhanced | Enhanced | null | 48 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 47: Leukemia - Hemostasis | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | 5,753 | 5 |
ENSG00000126562 | WNK4 | WNK lysine deficient protein kinase 4 | [
"Q96J92"
] | 17 | 42780610-42797066 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA016500"
] | [
"PRKWNK4"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Disease variant"
] | [] | [] | [] | [] | null | Approved | null | 6 | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 27: Breast cancer - Unknown function | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 4 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 5,754 | 2 |
ENSG00000126581 | BECN1 | Beclin 1 | [
"Q14457"
] | 17 | 42810134-42833350 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003949",
"CAB010143",
"HPA028949"
] | [
"ATG6",
"VPS30"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Antiviral defense",
"Apoptosis",
"Autophagy",
"Cell cycle",
"Cell division",
"Endocytosis",
"Host-virus interaction"
] | [] | [] | [
"Cytosol"
] | [
"Nuclear bodies"
] | [] | [] | Supported | Supported | null | 130 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 21: Non-specific - Metabolism | Cluster 27: Breast cancer - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 5,755 | 3 |
ENSG00000126583 | PRKCG | Protein kinase C gamma | [
"P05129"
] | 19 | 53879190-53907652 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA054560"
] | [
"MGC57564",
"PKCC",
"PKCG",
"PKCgamma",
"SCA14"
] | [
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [
"Biological rhythms"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Disease variant",
"FDA approved drug targets",
"Neurodegeneration",
"Spinocerebellar ataxia"
] | [] | [] | [] | [] | null | Enhanced | null | 11 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 19: Cerebellar purkinje cells - Neurotransmission & signaling | Cluster 10: Brain - Synaptic signal transduction | Tissue enriched | Detected in some | 26 | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,756 | 6 |
ENSG00000126603 | GLIS2 | GLIS family zinc finger 2 | [
"Q9BZE0"
] | 16 | 4314761-4339597 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062755",
"HPA065406"
] | [
"NPHP7"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Neurogenesis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Ciliopathy",
"Nephronophthisis"
] | [
"Nucleoplasm"
] | [
"Basal body"
] | [] | [] | Approved | null | null | 32 | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 88: Proximal tubular cells - Transmembrane transport | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,758 | 6 |
ENSG00000126653 | NSRP1 | Nuclear speckle splicing regulatory protein 1 | [
"Q9H0G5"
] | 17 | 30115521-30186475 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA015593",
"HPA015603"
] | [
"CCDC55",
"DKFZP434K1421",
"NSrp70"
] | [
"Disease related genes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"RNA-binding"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 31 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 6: Non-specific - Immune response | Cluster 27: Breast cancer - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 5,759 | 5 |
ENSG00000126698 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | [
"O75937"
] | 1 | 28199456-28233029 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026275",
"HPA026283"
] | [
"SPF31"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [
"Chaperone"
] | [] | [
"Nucleoplasm"
] | [
"Cytokinetic bridge",
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 70 | Yes | null | Cluster 29: Non-specific - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 17: Non-specific - RNA processing | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,760 | 5 |
ENSG00000126705 | AHDC1 | AT-hook DNA binding motif containing 1 | [
"Q5TGY3"
] | 1 | 27534035-27604431 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028648",
"HPA028685",
"HPA028691"
] | [
"DJ159A19.3",
"RP1-159A19.1"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 14 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 33: Sarcoma - Muscle contraction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 5,761 | 7 |
ENSG00000126709 | IFI6 | Interferon alpha inducible protein 6 | [
"P09912"
] | 1 | 27666064-27672212 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005543"
] | [
"6-16",
"FAM14C",
"G1P3",
"IFI-6-16",
"IFI616"
] | [
"Predicted membrane proteins"
] | [
"Antiviral defense",
"Apoptosis",
"Immunity",
"Innate immunity"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Approved | null | 1 | null | null | Cluster 28: Neutrophils - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 1: Choroid plexus - Transmembrane transport | Tissue enriched | Detected in all | 11 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 5 | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 5,762 | 5 |
ENSG00000126733 | DACH2 | Dachshund family transcription factor 2 | [
"Q96NX9"
] | X | 86148451-86832604 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA000258",
"HPA001367"
] | [] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | null | null | null | null | Cluster 14: Neurons - Synaptic function | Cluster 11: Neuronal - Sensory perception | Cluster 57: Podocytes - Glomerular filtration | Cluster 78: Brain - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 5,763 | 5 |
ENSG00000126746 | ZNF384 | Zinc finger protein 384 | [
"Q8TF68"
] | 12 | 6666477-6689572 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004051"
] | [
"CAGH1A",
"CIZ",
"NMP4",
"NP",
"TNRC1"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Supported | null | 5 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 55: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 5,764 | 5 |
ENSG00000126749 | EMG1 | EMG1 N1-specific pseudouridine methyltransferase | [
"Q92979"
] | 12 | 6970913-6979936 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039304",
"HPA039666"
] | [
"C2F",
"Grcc2f",
"NEP1"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis",
"rRNA processing"
] | [
"Methyltransferase",
"RNA-binding",
"rRNA-binding",
"Transferase"
] | [
"Disease variant"
] | [
"Nucleoli rim"
] | [
"Nucleoplasm",
"Mitotic chromosome"
] | [] | [] | Supported | Supported | null | 22 | Yes | No | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 30: Non-specific - Gene expression regulation | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 5,765 | 8 |
ENSG00000126752 | SSX1 | SSX family member 1 | [
"Q16384"
] | X | 48255392-48267444 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045683",
"HPA071685"
] | [
"CT5.1"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [] | [
"Cancer-related genes",
"Proto-oncogene"
] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | Supported | null | 4 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 51: Myeloma - Immunoglobulins | Cluster 3: Early primary spermatocytes - Early meiosis | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in single | 20 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,766 | 7 |
ENSG00000126756 | UXT | Ubiquitously expressed prefoldin like chaperone | [
"Q9UBK9"
] | X | 47651796-47659180 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA050499",
"HPA058400"
] | [
"ART-27",
"STAP1"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Chaperone",
"Repressor"
] | [] | [
"Centriolar satellite",
"Basal body"
] | [] | [] | [] | Approved | Approved | null | 110 | null | No | Cluster 18: Non-specific - Translation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 15: Non-specific - Protein processing | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,767 | 8 |
ENSG00000126759 | CFP | Complement factor properdin | [
"P27918"
] | X | 47623172-47630305 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA072644"
] | [
"PFC"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Complement alternate pathway",
"Immunity",
"Innate immunity"
] | [] | [
"Disease variant"
] | [
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Immunity"
] | Approved | null | null | 23 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 15: Non-specific - Transcription | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 102: Non-specific - Mixed function | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Group enriched | Detected in many | 6 | Cancer enriched | Detected in some | 9 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in all | 8 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 5,768 | 1 |
ENSG00000126767 | ELK1 | ETS transcription factor ELK1 | [
"P19419"
] | X | 47635521-47650604 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003808",
"HPA036084",
"HPA064381"
] | [] | [
"Predicted intracellular proteins",
"RAS pathway related proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Enhanced | null | 22 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 51: Neurons - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 5,769 | 9 |
ENSG00000126768 | TIMM17B | Translocase of inner mitochondrial membrane 17B | [
"O60830"
] | X | 48893447-48898143 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029093"
] | [
"DXS9822",
"JM3"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Protein transport",
"Translocation",
"Transport"
] | [] | [] | [
"Microtubules"
] | [
"Mitochondria"
] | [] | [] | Approved | Approved | null | 22 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,770 | 4 |
ENSG00000126773 | PCNX4 | Pecanex 4 | [
"Q63HM2"
] | 14 | 60091911-60169133 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002076",
"HPA003390"
] | [
"C14orf135",
"PCNXL4"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 1 | null | null | Cluster 15: NK-cells - Unknown function | Cluster 21: Non-specific - Metabolism | Cluster 30: Non-specific - Gene expression regulation | Cluster 103: Non-specific - Basic cellular processes | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,771 | 8 |
ENSG00000126775 | ATG14 | Autophagy related 14 | [
"Q6ZNE5"
] | 14 | 55366391-55411830 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB037242",
"CAB080659"
] | [
"ATG14L",
"KIAA0831"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Autophagy"
] | [] | [] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | [] | Approved | Approved | null | 49 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 34: Non-specific - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 6 | 2 | 5 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 5,772 | 1 |
ENSG00000126777 | KTN1 | Kinectin 1 | [
"Q86UP2"
] | 14 | 55559072-55701526 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003178",
"CAB015331",
"HPA017876"
] | [
"CG1",
"KIAA0004",
"KNT"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Enhanced | Enhanced | null | 32 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 50: Non-specific - Nucleic acid binding | Cluster 30: Non-specific - Gene expression regulation | Cluster 26: Keratinocytes - Keratinization | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,773 | 7 |
ENSG00000126778 | SIX1 | SIX homeobox 1 | [
"Q15475"
] | 14 | 60643421-60658259 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001893",
"CAB058690"
] | [
"DFNA23"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes",
"Deafness",
"Disease variant",
"Non-syndromic deafness"
] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Supported | Enhanced | null | 22 | No | No | null | Cluster 42: Choroid plexus - Mitochondria | Cluster 10: Ciliated cells - Ion channel activity | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 19: Skeletal muscle - Striated muscle contraction | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | 5,774 | 4 |
ENSG00000126785 | RHOJ | Ras homolog family member J | [
"Q9H4E5"
] | 14 | 63204114-63293508 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003050"
] | [
"ARHJ",
"FLJ14445",
"RASL7B",
"TCL"
] | [
"Predicted intracellular proteins"
] | [
"Angiogenesis"
] | [] | [] | [
"Plasma membrane"
] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | Approved | Uncertain | null | 29 | null | null | null | Cluster 32: Cerebral cortex - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 5,775 | 1 |
ENSG00000126787 | DLGAP5 | DLG associated protein 5 | [
"Q15398"
] | 14 | 55148112-55191608 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005546",
"HPA071028"
] | [
"DLG1",
"DLG7",
"HURP",
"KIAA0008"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle"
] | [] | [] | [
"Cytosol"
] | [
"Mitotic spindle"
] | [] | [] | Supported | Enhanced | null | 22 | Yes | Yes | Cluster 16: Non-specific - Cell proliferation | Cluster 11: White matter - Signal transduction | Cluster 30: Non-specific - Gene expression regulation | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Group enriched | Detected in many | 4 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 5 | 6 | 2 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 5,776 | 9 |
ENSG00000126790 | L3HYPDH | Trans-L-3-hydroxyproline dehydratase | [
"Q96EM0"
] | 14 | 59460363-59484408 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA056694"
] | [
"C14orf149",
"FLJ25436"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Lyase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Uncertain | Approved | null | 7 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 50: Non-specific - Nucleic acid binding | Cluster 7: Liver cancer - Metabolism | Cluster 89: Adipocytes - Lipid metabolism | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 5,777 | 4 |
ENSG00000126803 | HSPA2 | Heat shock protein family A (Hsp70) member 2 | [
"P54652"
] | 14 | 64535905-64546173 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000798",
"HPA052504"
] | [] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis",
"Stress response"
] | [
"Chaperone"
] | [
"Cancer-related genes"
] | [
"Vesicles",
"Flagellar centriole",
"Annulus"
] | [
"Perinuclear theca",
"Calyx"
] | [] | [] | Approved | Enhanced | Supported | 133 | null | null | null | Cluster 30: White matter - Myelination | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 5,778 | 3 |
ENSG00000126804 | ZBTB1 | Zinc finger and BTB domain containing 1 | [
"Q9Y2K1"
] | 14 | 64503712-64533690 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA050516",
"HPA054552"
] | [
"KIAA0997",
"ZNF909"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"DNA damage",
"DNA repair",
"Immunity",
"Innate immunity",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear membrane"
] | [] | [] | Supported | Approved | null | 20 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 103: Non-specific - Basic cellular processes | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,779 | 3 |
ENSG00000126814 | TRMT5 | TRNA methyltransferase 5 | [
"Q32P41"
] | 14 | 60971441-60981170 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000943"
] | [
"KIAA1393",
"TRM5"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"tRNA processing"
] | [
"Methyltransferase",
"Transferase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | Supported | null | 2 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 30: Non-specific - Gene expression regulation | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 5,780 | 8 |
ENSG00000126821 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | [
"Q9BX95"
] | 14 | 63684216-63728065 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053149",
"HPA064908"
] | [] | [
"Metabolic proteins",
"Predicted membrane proteins"
] | [
"Lipid metabolism"
] | [
"Hydrolase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 7 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 30: White matter - Myelination | Cluster 46: Lymphoma - Humoral immune response | Cluster 102: Non-specific - Mixed function | Cluster 36: Brain & Liver - Signaling | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 5,781 | 7 |
ENSG00000126822 | PLEKHG3 | Pleckstrin homology and RhoGEF domain containing G3 | [
"A1L390"
] | 14 | 64704102-64750249 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA063455",
"HPA073702",
"HPA074734"
] | [
"ARHGEF43",
"KIAA0599"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Cytosol"
] | [] | [] | Uncertain | Enhanced | null | 13 | null | No | Cluster 21: Neutrophils - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 64: Renal epithelial cells - Ion transport & homeostasis | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,782 | 5 |
ENSG00000126856 | PRDM7 | PR/SET domain 7 | [
"Q9NQW5"
] | 16 | 90056566-90092072 | Evidence at protein level | No human protein/transcript evidence | Evidence at protein level | Evidence at protein level | [
"HPA059944"
] | [
"ZNF910"
] | [
"Predicted intracellular proteins"
] | [] | [
"Chromatin regulator",
"Methyltransferase",
"Transferase"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Uncertain | Approved | null | 1 | null | null | null | null | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 3: Early primary spermatocytes - Early meiosis | null | Not detected | Not detected | null | Cancer enriched | Detected in single | 25 | Not detected | Not detected | null | Cell type enriched | Detected in some | 35 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,784 | 3 |
ENSG00000126858 | RHOT1 | Ras homolog family member T1 | [
"Q8IXI2"
] | 17 | 32142454-32253374 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA010687",
"CAB068223",
"CAB068224"
] | [
"ARHT1",
"FLJ11040",
"MIRO-1",
"MIRO1"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase"
] | [] | [] | [] | [] | [] | null | Supported | null | 13 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 34: Non-specific - Mixed function | Cluster 1: Neuronal - Visual perception | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,785 | 2 |
ENSG00000126860 | EVI2A | Ecotropic viral integration site 2A | [
"P22794"
] | 17 | 31316410-31321749 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045033"
] | [
"EVDA",
"EVI2"
] | [
"Predicted membrane proteins"
] | [] | [] | [
"Proto-oncogene"
] | [
"Golgi apparatus",
"Vesicles",
"Plasma membrane",
"Primary cilium"
] | [
"Primary cilium transition zone",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 8 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 3: Oligodendrocytes - Myelination | Group enriched | Detected in many | 4 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 5,786 | 2 |
ENSG00000126861 | OMG | Oligodendrocyte myelin glycoprotein | [
"P23515"
] | 17 | 31272013-31297539 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008206",
"HPA012693"
] | [
"OMGP"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell adhesion"
] | [] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Cell adhesion"
] | null | Enhanced | null | 1 | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in some | 4 | Not detected | Not detected | null | Cancer enriched | Detected in some | 14 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 5,787 | 9 |
ENSG00000126870 | DYNC2I1 | Dynein 2 intermediate chain 1 | [
"Q8WVS4"
] | 7 | 158856558-158956747 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020607",
"HPA021316"
] | [
"CFAP163",
"DIC6",
"FAP163",
"FLJ10300",
"WDR60"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Cilium biogenesis/degradation"
] | [] | [
"Ciliopathy",
"Disease variant"
] | [
"Centrosome",
"Basal body"
] | [
"Primary cilium",
"Cytosol"
] | [] | [] | Supported | Approved | null | 28 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 39: Non-specific - Transcription | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,788 | 1 |
ENSG00000126882 | FAM78A | Family with sequence similarity 78 member A | [
"Q5JUQ0"
] | 9 | 131258076-131277365 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA021472",
"HPA023914"
] | [
"C9orf59",
"FLJ00024"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles"
] | [] | [
"Intracellular and membrane"
] | [
"No annotated function"
] | Uncertain | Uncertain | null | 2 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 41: Striated muscle - Muscle contraction | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | 5,790 | 7 |
ENSG00000126883 | NUP214 | Nucleoporin 214 | [
"P35658"
] | 9 | 131125573-131234663 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CAIN",
"CAN",
"D9S46E",
"N214"
] | [
"Cancer-related genes",
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Host-virus interaction",
"mRNA transport",
"Protein transport",
"Translocation",
"Transport"
] | [] | [
"Cancer-related genes",
"Disease variant",
"Proto-oncogene"
] | [] | [] | [] | [] | null | null | null | 50 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 6: Non-specific - Immune response | Cluster 43: Non-specific - Basic cellular processes | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Group enriched | Detected in all | 5 | 0 | 0 | 0 | [] | [] | [] | 5,791 | 1 |
ENSG00000126890 | CTAG2 | Cancer/testis antigen 2 | [
"O75638"
] | X | 154651972-154653579 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071467"
] | [
"CAMEL",
"CT6.2a",
"CT6.2b",
"ESO2",
"LAGE-1",
"LAGE-1a",
"LAGE-1b",
"LAGE1",
"MGC138724",
"MGC3803"
] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 2 | null | null | null | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 35: Non-specific - Mixed function | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,792 | 9 |
ENSG00000126895 | AVPR2 | Arginine vasopressin receptor 2 | [
"P30518"
] | X | 153902531-153907166 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"DIR",
"DIR3",
"V2R"
] | [
"Disease related genes",
"FDA approved drug targets",
"G-protein coupled receptors",
"Human disease related genes",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Diabetes insipidus",
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | null | null | 4 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 35: Non-specific - DNA binding | Cluster 70: DU4475 - Unknown function | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 4 | Group enriched | Detected in some | 28 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 5,793 | 1 |
ENSG00000126903 | SLC10A3 | Solute carrier family 10 member 3 | [
"P09131"
] | X | 154487306-154490690 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA021656"
] | [
"DXS253E",
"P3"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Symport",
"Transport"
] | [] | [] | [
"Intermediate filaments"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 41: Basophils - Unknown function | Cluster 18: Non-specific - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in all | 10 | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 5,794 | 5 |
ENSG00000126947 | ARMCX1 | Armadillo repeat containing X-linked 1 | [
"Q9P291"
] | X | 101550547-101554700 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000268",
"HPA005685",
"CAB020695"
] | [
"ALEX1",
"GASP7"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Supported | Supported | null | 6 | No | No | Cluster 2: Dendritic cells - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 33: Sarcoma - Muscle contraction | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 5,797 | 7 |
ENSG00000126950 | TMEM35A | Transmembrane protein 35A | [
"Q53FP2"
] | X | 101078879-101096367 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048583"
] | [
"FLJ14084",
"NACHO",
"TMEM35",
"TUF-1"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [
"Chaperone"
] | [] | [
"Vesicles"
] | [
"Focal adhesion sites",
"Cytosol"
] | [] | [] | Supported | Enhanced | Supported | 22 | null | null | null | Cluster 1: Neurons - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe"
] | [
"Glioblastoma Multiforme",
"Kidney Chromophobe",
"Lung Adenocarcinoma"
] | 5,798 | 7 |
ENSG00000126953 | TIMM8A | Translocase of inner mitochondrial membrane 8A | [
"O60220"
] | X | 101345661-101348742 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003628"
] | [
"DDP",
"DFN1",
"MTS"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Translocation",
"Transport"
] | [
"Chaperone"
] | [
"Deafness",
"Disease variant",
"Dystonia"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Supported | null | 19 | null | null | Cluster 18: Non-specific - Translation | Cluster 14: Neurons - Synaptic function | Cluster 49: HMC-1 - Innate immune response | Cluster 26: Keratinocytes - Keratinization | Cluster 16: Liver & Kidney - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 6 | 0 | 6 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma",
"Prostate Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Prostate Adenocarcinoma"
] | 5,799 | 7 |
ENSG00000126970 | ZC4H2 | Zinc finger C4H2-type containing | [
"Q9NQZ6"
] | X | 64915802-65034713 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA049584"
] | [
"HCA127",
"KIAA1166",
"MCS",
"MRXS4",
"WWS"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Differentiation"
] | [
"Developmental protein"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Vesicles",
"Microtubules",
"Primary cilium"
] | [
"Basal body"
] | [] | [] | Approved | Approved | null | 18 | null | null | Cluster 24: Non-specific - Transcription | Cluster 49: Hindbrain - Mixed function | Cluster 6: Leukemia - Signal transduction | Cluster 7: Non-specific - Transcription | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Thyroid Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | 5,800 | 7 |
ENSG00000127022 | CANX | Calnexin | [
"P27824"
] | 5 | 179678628-179731641 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004738",
"HPA009433",
"HPA009696"
] | [
"CNX",
"IP90",
"P90"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Host-virus interaction"
] | [
"Chaperone"
] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Enhanced | Enhanced | null | 785 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in all | 5 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Ovary Serous Cystadenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Ovary Serous Cystadenocarcinoma"
] | 5,801 | 5 |
ENSG00000127054 | INTS11 | Integrator complex subunit 11 | [
"Q5TA45"
] | 1 | 1311585-1324687 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028379",
"HPA029025"
] | [
"CPSF3L",
"CPSF73L",
"FLJ20542",
"INT11",
"RC-68"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [
"Intellectual disability"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 46 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 37: Neurons - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 5,802 | 6 |
ENSG00000127074 | RGS13 | Regulator of G protein signaling 13 | [
"O14921"
] | 1 | 192636138-192660311 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA076656"
] | [] | [
"Predicted intracellular proteins"
] | [] | [
"Signal transduction inhibitor"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | Cluster 32: Basophils - Transcription | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 58: Mast cells - Allergic inflammatory responses | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in some | 8 | Cancer enriched | Detected in some | 13 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 4 | Immune cell enriched | Detected in single | 39 | 0 | 0 | 0 | [] | [] | [] | 5,803 | 8 |
ENSG00000127080 | IPPK | Inositol-pentakisphosphate 2-kinase | [
"Q9H8X2"
] | 9 | 92613183-92670131 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020603"
] | [
"C9orf12",
"FLJ13163",
"INSP5K2",
"IP5K",
"IPK1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 33: Non-specific - ATP binding | Cluster 37: Neurons - Mixed function | Cluster 43: Non-specific - Basic cellular processes | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 5,804 | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.